127 related articles for article (PubMed ID: 27385126)
1. Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers.
Tekcham DS; Tiwari PK
Asia Pac J Clin Oncol; 2016 Dec; 12(4):332-348. PubMed ID: 27385126
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
Singh TD; Gupta S; Shrivastav BR; Tiwari PK
Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation as an epigenetic regulator of gallbladder cancer: An overview.
Muhammad JS; Khan MR; Ghias K
Int J Surg; 2018 May; 53():178-183. PubMed ID: 29602013
[TBL] [Abstract][Full Text] [Related]
4. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.
Sharma P; Bhunia S; Poojary SS; Tekcham DS; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
Tumour Biol; 2016 Nov; 37(11):14687-14699. PubMed ID: 27623942
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of
Tekcham DS; Poojary SS; Bhunia S; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
Indian J Med Res; 2016 May; 143(Supplement):S82-S90. PubMed ID: 27748282
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Biomarkers in Gallbladder Cancer.
Tiwari PK
Trends Cancer; 2020 Jul; 6(7):540-543. PubMed ID: 32291238
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Downregulation of PTEN in Gallbladder Cancer.
Tekcham DS; Gupta S; Shrivastav BR; Tiwari PK
J Gastrointest Cancer; 2017 Mar; 48(1):110-116. PubMed ID: 28124240
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
[TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
[TBL] [Abstract][Full Text] [Related]
11. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.
Brägelmann J; Barahona Ponce C; Marcelain K; Roessler S; Goeppert B; Gallegos I; Colombo A; Sanhueza V; Morales E; Rivera MT; de Toro G; Ortega A; Müller B; Gabler F; Scherer D; Waldenberger M; Reischl E; Boekstegers F; Garate-Calderon V; Umu SU; Rounge TB; Popanda O; Lorenzo Bermejo J
Hepatology; 2021 Jun; 73(6):2293-2310. PubMed ID: 33020926
[TBL] [Abstract][Full Text] [Related]
12. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
13. WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival.
Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y
Gene; 2017 Jul; 622():42-49. PubMed ID: 28438695
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression.
Bhunia S; Barbhuiya MA; Gupta S; Shrivastava BR; Tiwari PK
Indian J Med Res; 2020 Apr; 151(4):311-318. PubMed ID: 32461394
[TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.
Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A
Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965
[TBL] [Abstract][Full Text] [Related]
16. c‑Jun suppresses the expression of WNT inhibitory factor 1 through transcriptional regulation and interaction with DNA methyltransferase 1 in gallbladder cancer.
Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y
Mol Med Rep; 2018 Jun; 17(6):8180-8188. PubMed ID: 29693707
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Frequently Down-Regulated Phosphatidylethanolamine-Binding Protein-1 in Gallbladder Cancer.
Bharti A; Ansari MA; Tewari M; Narayan G; Singh S
Dig Dis Sci; 2024 Feb; 69(2):502-509. PubMed ID: 38135812
[TBL] [Abstract][Full Text] [Related]
18. Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.
Kagohara LT; Schussel JL; Subbannayya T; Sahasrabuddhe N; Lebron C; Brait M; Maldonado L; Valle BL; Pirini F; Jahuira M; Lopez J; Letelier P; Brebi-Mieville P; Ili C; Pandey A; Chatterjee A; Sidransky D; Guerrero-Preston R
Future Oncol; 2015; 11(2):233-49. PubMed ID: 25066711
[TBL] [Abstract][Full Text] [Related]
19. Role of DNA methylation in imprinting disorders: an updated review.
Elhamamsy AR
J Assist Reprod Genet; 2017 May; 34(5):549-562. PubMed ID: 28281142
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]